Texas reinstates synthetic cannabinoid ban following Supreme Court ruling

State moves to restore Schedule I classification for synthetic cannabinoids after court action, escalating regulatory uncertainty in hemp market.

FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0

Texas has reinstated a Schedule I ban on synthetic cannabinoids following a Supreme Court ruling, according to Vicente LLP. The action signals a tightening regulatory posture even as the state expands its medical cannabis program—a contrast underscored by concurrent approvals of new dispensary locations in Austin, Dallas, and San Antonio, plus the first authorized vaporization devices.

The reinstatement appears to target the broader hemp-derived cannabinoid market that has operated in legal gray space. This move echoes months of regulatory tension: Texas blocked smokeable hemp sales in spring 2026, faced legal challenges from businesses, and saw a temporary court order halt the ban before the present action. The sequence suggests state officials are attempting to narrow the legal perimeter around non-traditional cannabinoid products.

Watch whether the reinstatement triggers fresh litigation from hemp businesses or affects the Phase II expansion of the Compassionate Use Program—and whether lawmakers, expected to consider broader cannabis regulation in 2027, address synthetic cannabinoid policy as part of that broader framework.